Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
about
The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reductionSchistosome-Derived Molecules as Modulating Actors of the Immune System and Promising Candidates to Treat Autoimmune and Inflammatory DiseasesHigh Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived LipopolysaccharideInterleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse modelsMechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteinsGenetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations.Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.Animal models of atherosclerosis.Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.Sex differences in stroke.An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes.Effects of Cigarette Smoke, Cessation, and Switching to Two Heat-Not-Burn Tobacco Products on Lung Lipid Metabolism in C57BL/6 and Apoe-/- Mice-An Integrative Systems Toxicology AnalysisVASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.Molecular biology of atherosclerosis.Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?Effects of 4-Pyridone-3-carboxamide-1β-D-ribonucleoside on adenine nucleotide catabolism in the aortic wall; Implications for atherosclerosis in ApoE-/-LDLR-/- mice.Absence of the Vitamin D Receptor Inhibits Atherosclerotic Plaque Calcification in Female Hypercholesterolemic Mice.Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.Sequential colonization of periodontal pathogens in induction of periodontal disease and atherosclerosis in LDLRnull mice.Current knowledge on the mechanism of atherosclerosis and pro-atherosclerotic properties of oxysterols.Is hypercholesterolemia a friend or a foe of tuberculosis?CD11c/CD18 Signals Very Late Antigen-4 Activation To Initiate Foamy Monocyte Recruitment during the Onset of Hypercholesterolemia.ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.Distinct metabolic and vascular effects of dietary triglycerides and cholesterol in atherosclerotic and diabetic mouse models.Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis.AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation.Mouse strain differences in metabolic fluxes and function of ex vivo working hearts.A Quantitative Model of Early Atherosclerotic Plaques Parameterized Using In Vitro Experiments.β-glucans and cholesterol (Review).Changes in arterial function in a mouse model of human familial hypercholesterolaemia.Low-density lipoprotein 4: a novel predictor of coronary artery disease severity.
P2860
Q26747185-85EBB0E1-D85F-461A-B8DB-B518F979D3CCQ28075563-CD7289A1-9E21-48D4-9B0A-5DBAFDC971AFQ28551030-811E7DE7-CEF5-4CB6-8091-FB433C73433BQ34520320-53014417-7DFA-489C-AA7A-39CE4740FEF9Q34557497-6907E305-546A-43C2-8739-ECD3CBAD6608Q35063189-B7C6FC86-9758-4130-B577-CC131D823EF2Q35732509-D7833920-DB2C-4F9E-B638-587D21864CF1Q35737165-15C0EB04-7E40-49F6-B7B2-6FD854B1FC1FQ35903298-D606FA52-D51A-4010-90F5-70D8138F9BB0Q36045565-E4369EA9-1007-4516-B22E-4BE557E763D8Q36130584-C14CFD78-8F7C-4A65-8C6B-494A7B56A589Q36459100-72C4815A-B4B1-4BCB-8EBB-1B5DE149586FQ36498669-28D48E3A-550A-469B-B896-95F61D0ACB12Q36498673-0A5A3945-31DE-4653-9CEB-DF1016CD69A3Q37077297-EA8BFD13-A44E-4831-9CC7-C33278E0143DQ38125279-14074B7C-B579-4A98-9250-62B920C435DEQ38888696-3BD48B3B-5391-4EB8-A193-40C809104886Q39139689-597738AD-A71C-4A88-B7B5-0DB100E9EA72Q39448176-59D33F42-24E1-43E4-8A87-CC7677B8A6A6Q39626523-30F2C124-D37F-4214-9A64-6973E7E8EB72Q40365024-BECEEE35-9E65-4197-8784-F52405DE2692Q42284817-65ED3A61-0158-44D5-858B-5F6B7F39C9E1Q42578288-EA40B8DD-F687-4DD4-A8DB-CA759C813F4BQ42629748-E4DDAC51-9C6D-4E2C-86D1-855942BE0B13Q44138808-DBFB662F-A688-4874-BA61-95EDF1F715ADQ44463693-724D8387-59C9-4D45-861F-9D81C25D85DCQ44879920-7EE63FEA-7D56-47FA-9C0A-1D34A7BBAE77Q46399403-67C12535-4D9B-418C-A703-C460A182E2BAQ46733241-2991A172-0086-44B3-9870-BEAC07CDB613Q47308158-4B05CE66-17D7-40EB-B5D2-ABEC5C49FCC6Q49379869-E8F0FD1E-CFBB-49A4-882F-BA6698AFF0D0Q52879060-1A20B000-6534-42E4-929B-790FAB87B7E4Q53120863-B3574C03-2FBA-4632-BD8C-3D5A53A3B434
P2860
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lipoprotein size and atherosclerosis susceptibility in Apoe
@nl
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
@ast
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
@en
type
label
Lipoprotein size and atherosclerosis susceptibility in Apoe
@nl
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
@ast
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
@en
prefLabel
Lipoprotein size and atherosclerosis susceptibility in Apoe
@nl
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
@ast
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
@en
P356
P1476
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice
@en
P2093
M M Véniant
S Withycombe
P304
P356
10.1161/HQ1001.097780
P407
P577
2001-10-01T00:00:00Z